Evidence map›Paper›PMID 30893336›Full record

ArticlePloS one2019

Epidemiologic profile of measles in Central African Republic: A nine year survey, 2007-2015.

Alain Farra, Tuspin Nicephore Loumandet, Marilou Pagonendji, Alexandre Manirakiza, Casimir Manengu, Raphaël Mbaïlao, Severin Ndjapou, Alain Lefaou, Ionela Gouandjika-Vasilache

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alain FarraNational Mycobacteriology Laboratory, Institut Pasteur of Bangui, Bangui, Central African Republic.ORCID 0000-0003-0420-4185
Tuspin Nicephore LoumandetHealth Sciences Faculty, University of Bangui, Bangui, Central African Republic.
Marilou PagonendjiEnteric Virus and Measles Laboratory, Institut Pasteur of Bangui, Bangui, Central African Republic.
Alexandre ManirakizaEpidemiology Unit, Institut Pasteur of Bangui, Bangui, Central African Republic.ORCID 0000-0003-3861-131X
Casimir ManenguWorld Health Organization Focal Point for Immunization, Vaccines and Emergencies, Bangui, Central African Republic.
Raphaël MbaïlaoExpanded Programme on Immunization, Ministry of Health, Bangui, Central African Republic.
Severin NdjapouEpidemiological Surveillance Service, Ministry of Health, Bangui, Central African Republic.
Alain LefaouPharmacy Faculty, Nancy, France.
Ionela Gouandjika-VasilacheEnteric Virus and Measles Laboratory, Institut Pasteur of Bangui, Bangui, Central African Republic.

Funding

World Health Organization 001
6 · The paper itself

Abstract

introductionMeasles remains a major public health problem in many developing countries in which vaccination coverage is poor, as is the case in the Central African Republic (CAR). At the beginning of the 2000s, a surveillance system was established in the country, and samples from suspected cases are regularly tested in the laboratory for serological confirmation. Since 2007, when case-by-case monitoring with standardized laboratory databases and monitoring, was set up, no assessment have been performed. Therfore, 9 years later it seemed appropriate to make a first assessment. The aim of the study reported here was to describe the epidemiology of measles in the CAR on the basis of surveillance and laboratory data.

methodA descriptive retrospective study was conducted, based on the databases of the measles surveillance programme and of the Institut Pasteur laboratory in Bangui during the period 2007-2015.

resultsDuring this study period, the surveillance programme notified 3767 cases. Of these, 2795 (75%) were sent for laboratory confirmation, and 24.6% (687/2795) were confirmed serologically. Of the 1797 cases of measles declared during this period by the surveillance programme, 1110 (61.8%) were confirmed clinically or by epidemiological linkage. The majority of confirmed cases (83.7%; 575/687) occurred in children under 10 years, over half of whom (44.2%; 304/687) were aged 1-4 years. Epidemics occurred regularly between 2011 and 2015, with > 10% of laboratory-confirmed cases. The rate of laboratory investigation was < 80% between 2011 and 2013 but nearly 100% in the other years.

conclusionMeasles remains a common, endemic illness in the CAR. Improved detection will require better measles surveillance, increased vaccination coverage, revision of the investigation forms to include the WHO case definition and training of the health personnel involved in case-finding in the field.

Indexed as

AdolescentAdultCentral African RepublicChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleMeaslesRetrospective StudiesSurveys and QuestionnairesYoung Adult

Identifiers

PMID30893336
PMCPMC6426189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.